Blog Archive
-
▼
2008
(66)
-
▼
February
(13)
- Genfit and Pierre Fabre, alliance
- UCB and sanofi-aventis, FDA Approves XYZAL® (levoc...
- LFB and the French Rare Diseases Alliance, Partner...
- IPSOGEN, Genomic Grade to improve Breast Cancer di...
- Sanofi Pasteur and Statens Serum Institut , develo...
- NOVEXEL AND FOREST LABORATORIES, LICENSE AGREEMENT...
- Trophos, grant from The Michael J. Fox Foundation ...
- Servier, Medicinal Chemistry Research Center in Bu...
- Faust Pharmaceuticals, Research Agreement with Takeda
- Tornier and Bioset Collaborate on Products for Ort...
- Novagali Pharma, FDA Clearance of IND for US Clini...
- Ipsen, a Biologics License Application (BLA) for D...
- Cerep, to provide profiling services to support a ...
-
▼
February
(13)
Tuesday, February 12, 2008
Servier, Medicinal Chemistry Research Center in Budapest
31 January 2008 - Servier, the leading independent French pharmaceutical group, inaugurated in Budapest a new Medicinal Chemistry Research Center. Staffed by over fifty researchers, this center will be an integral part of the Institut de Recherche Servier (IDRS) and will participate in IDRS research programs, with a particular focus on metabolic diseases and oncology... Servier's Press Release - Communiqué de Presse de Servier-